Nomura Holdings’s Takeda Pharmaceutical TAK Stock Holding History

Nomura Holdings’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,700	Closed	-$338K	–	1928
2025 Q1	$338K	Buy	+22,700	New	+$318K	﹤0.01%	1580
2024 Q4	–	Sell	-25,000	Closed	-$356K	–	2390
2024 Q3	$356K	Buy	+25,000	New	+$355K	﹤0.01%	1317
2024 Q2	–	Sell	-16,800	Closed	-$233K	–	2015
2024 Q1	$233K	Sell	16,800 -190,800	-92%	-$2.77M	﹤0.01%	1424
2023 Q4	$2.96M	Buy	+207,600	New	+$2.95M	0.01%	838
2023 Q3	–	Sell	-364,302	Closed	-$5.72M	–	1631
2023 Q2	$5.72M	Buy	+364,302	New	+$5.97M	0.02%	458
2022 Q4	–	Sell	-128,600	Closed	-$1.67M	–	1702
2022 Q3	$1.67M	Buy	+128,600	New	+$1.79M	0.01%	845
2021 Q1	–	Sell	-215,000	Closed	-$3.91M	–	2263
2020 Q4	$3.91M	Buy	215,000 +130,000	+153%	+$2.28M	0.01%	637
2020 Q3	$1.52M	Buy	85,000 +17,500	+26%	+$319K	﹤0.01%	720
2020 Q2	$1.22M	Sell	67,500 -35,000	-34%	-$628K	﹤0.01%	667
2020 Q1	$1.55M	Sell	102,500 -17,500	-15%	-$317K	0.01%	515
2019 Q4	$2.37M	Sell	120,000 -165,000	-58%	-$3.16M	0.01%	620
2019 Q3	$4.94M	Hold	285,000	–	–	0.02%	466
2019 Q2	$5.04M	Sell	285,000 -117,500	-29%	-$2.14M	0.02%	469
2019 Q1	$8.25M	Buy	+402,500	New	+$8.1M	0.03%	343

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Nomura Holdings's TAK Position: Q2 2025 in Review

Nomura Holdings sold out of Takeda Pharmaceutical (TAK) in Q2 2025, closing a stake of 22,700 shares — an estimated $338K sold.

Nomura Holdings first reported a position in TAK in Q1 2019 and held it in 14 quarters. The position peaked at $8.25M in Q1 2019. 315 funds tracked by Wall St. Rank hold TAK as of Q2 2025.

Nomura Holdings reported no remaining Takeda Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Nomura Holdings sold 22,700 Takeda Pharmaceutical shares in Q2 2025, an estimated $338K.
Nomura Holdings first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 14 quarters.
Nomura Holdings's Takeda Pharmaceutical position peaked at $8.25M in Q1 2019.
315 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.